Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
Eligibility criteria
Qualifiers
Age ≥18 years
Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology
Disqualifiers
Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years
History of chemotherapy or radiation therapy for a previous lung cancer
Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery
Carcinoid tumors
Trial design
Treatments tested in this trial
- Patient-Reported Outcomes Measurement Information System
Treatment groups
600 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov